Trifluoroacetic acid methylene chloride → HCID 59684239, compound
Reaction equation
[C:1]([NH:5][C:6](=[O:38])[CH2:7][N:8]1[C:17]([C:18]2[CH:23]=[CH:22][C:21]([F:24])=[C:20]([O:25][CH3:26])[CH:19]=2)=[CH:16][C:15]2[C:10](=[CH:11][C:12]([O:27]CC3C=CC(OC)=CC=3)=[CH:13][CH:14]=2)[C:9]1=[O:37])([CH3:4])([CH3:3])[CH3:2].C(O)(C(F)(F)F)=O.C(Cl)Cl>>[C:1]([NH:5][C:6](=[O:38])[CH2:7][N:8]1[C:17]([C:18]2[CH:23]=[CH:22][C:21]([F:24])=[C:20]([O:25][CH3:26])[CH:19]=2)=[CH:16][C:15]2[C:10](=[CH:11][C:12]([OH:27])=[CH:13][CH:14]=2)[C:9]1=[O:37])([CH3:4])([CH3:2])[CH3:3]Participants
3
Procedure
N-tert-Butyl-2-(3-(4-fluoro-3-methoxyphenyl)-7-(4-methoxybenzyloxy)-1-oxo-1H-isoquinolin-2-yl)acetamide (120 mg, 0.231 mmol) was treated with TFA:DCM (1:1 v/v, 5 mL) and stirred at room temperature for 1 h. The mixture was concentrated in vacuo and the crude residue was purified by preparative HPLC giving N-tert-butyl-2-(3-(4-fluoro-3-methoxyphenyl)-7-hydroxy-1-oxo-1H-isoquinolin-2-yl)acetamide (INTERMEDIATE III.1) (25 mg, 0.063 mmol, 27%).
Workup
- concentrationThe mixture was concentrated in vacuo
- customthe crude residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-4d3310899c52456eb1cddf36360e4a39
- Source dataset
- uspto-grants-2011_03
- Patent number
- US07906504B2
Reaction notes
Loading…